OraSure Technologies, Inc. (OSUR)

Market Cap	253.80M +13.4%
Revenue (ttm)	112.41M -18.9%
Net Income	-49.13M
EPS	-0.69
Shares Out	68.97M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	659,171
Open	3.610
Previous Close	3.610
Day's Range	3.590 - 3.700
52-Week Range	2.080 - 4.580
Beta	1.02
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 4, 2026

About OSUR

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid tes...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 12, 1986
• Employees: 500
• Stock Exchange: Nasdaq
• Ticker Symbol: OSUR
• Website: https://www.orasure.com

Financial Performance

In 2025, OraSure Technologies's revenue was $115.02 million, a decrease of -38.10% compared to the previous year's $185.83 million. Losses were -$68.73 million, 252.5% more than in 2024.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 20, 2026

Data Sources Report a data error